Abingworth LLP
- SEC CIK
- 0001397144
- Latest filing
- Feb 10, 2023
SYRE holding history
Spyre Therapeutics, Inc. in every 13F filed by Abingworth LLP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
SYRE overviewAll 13F holders of SYREFull Q4 2022 holdings
- Shares (Q4 2022)
- 240,500
- Value
- $108.2K
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q4 2022 | 240,500 | $108.2K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2022 | 240,500 | $127.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2022 | 240,500 | $121.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2022 | 240,500 | $553.0K | 0.2% | 00.0% | Unchanged | Holders |
| Q4 2021 | 240,500 | $1.14M | 0.3% | 00.0% | Unchanged | Holders |
| Q3 2021 | 240,500 | $1.91M | 0.4% | 00.0% | Unchanged | Holders |
| Q2 2021 | 240,500 | $1.67M | 0.5% | 00.0% | Unchanged | Holders |
| Q1 2021 | 240,500 | $1.90M | 0.7% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.